Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[How to perform intravitreal injections].

J-F Korobelnik1, I Cochereau, S-Y Cohen

  • 1Service d'Ophtalmologie, CHU Pellegrin, Bordeaux. jean-francois.korobelnik@chu-bordeaux.fr

Journal Francais D'Ophtalmologie
|February 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of transesophageal echocardiography guidance for pulmonary artery banding in a cat with ventricular septal defect.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2026
Same author

PICCTURE: Survey of French ophthalmologists' practices for the treatment of neovascular age-related macular degeneration patients currently treated with anti-VEGF.

Journal francais d'ophtalmologie·2026
Same author

[Mirvetuximab soravtansine-associated microcystic keratopathy].

Journal francais d'ophtalmologie·2026
Same author

Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration - The OCTOPUS cohort study.

Journal francais d'ophtalmologie·2025
Same author

Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration - The SWIFT study.

Journal francais d'ophtalmologie·2025
Same author

[Recommendations for rational use of new anti-VEGF biologicals].

Journal francais d'ophtalmologie·2025

Intravitreal injections for retinal diseases can cause complications. Minimizing risks involves rigorous antisepsis, sterile techniques, and immediate post-injection follow-up for patient safety.

Area of Science:

  • Ophthalmology
  • Retinal Disease Treatment
  • Surgical Safety

Context:

  • Intravitreal injections are a common drug delivery method for retinal diseases.
  • These injections carry a risk of severe complications.
  • Standardized protocols are needed to enhance patient safety.

Purpose:

  • To outline essential techniques for minimizing complications associated with intravitreal injections.
  • To emphasize the importance of preoperative antisepsis and sterile environments.
  • To highlight the role of immediate post-injection follow-up.

Summary:

  • Rigorous preoperative antisepsis using povidone iodine is crucial.
  • Maintaining a sterile environment, including personal protective equipment and sterile instruments, is essential.

Related Experiment Videos

  • Immediate follow-up care after the injection is a key component of the technique.

    • Impact:

    • Reduced incidence of severe complications from intravitreal injections.
    • Improved safety profile for patients undergoing retinal disease treatment.
    • Enhanced best practices for ophthalmic procedures involving intravitreal drug delivery.